[
    [
        {
            "time": "2018-07-01",
            "original_text": "How PayPal Holdings Inc and Other Hedge Fund Favorites Performed in Q2",
            "features": {
                "keywords": [
                    "PayPal",
                    "Hedge Fund",
                    "Favorites",
                    "Performed",
                    "Q2"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "How PayPal Holdings Inc and Other Hedge Fund Favorites Performed in Q2",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-10-15",
            "original_text": "For Apple, China Is an Irritant, and “Wind of Opportunity”",
            "features": {
                "keywords": [
                    "Apple",
                    "China",
                    "Irritant",
                    "Opportunity"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "technology",
                    "international trade"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "For Apple, China Is an Irritant, and “Wind of Opportunity”",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-11-22",
            "original_text": "AbbVie Is Buying Allergan. That’s Not the Right Remedy for the Stock.",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Allergan",
                    "Buying",
                    "Remedy",
                    "Stock"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie Is Buying Allergan. That’s Not the Right Remedy for the Stock.",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 10,
                "Impact": 9,
                "Duration": 10,
                "Entity_Density": 10,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]